Supported cancer types
IndiTreat® is for cancer therapy selection
With IndiTreat®, you can test different panels of drugs and drug combinations on microtumors derived from individual patients to identify resistance and sensitivity.
IndiTreat® CE IVD Colorectal Cancer Test
A method of determining which drugs offer the most suitable therapies for different patients with stage III–IV colorectal cancer, this test can be used before:
- Postoperative adjuvant therapy
- Neoadjuvant therapy
- 1st and 2nd line therapy of metastatic disease
- Therapy of end-stage metastatic patients
- HIPEC (hyperthermic intraperitoneal chemotherapy)
IndiTreat® Ovarian Cancer Test
This test indicates which panels offer the most suitable therapies for different patients with ovarian cancer. Multi-center clinical validation trials are ongoing. This test is used before:
- Postoperative adjuvant therapy
- Neoadjuvant therapy
- Therapy of recurrence regardless of previous platinum response
- Selection of the most effective PARP-inhibitor in BRCA-mt patients
- Selection of BRCA-wt patients who shall benefit from PARP-inhibition
- Therapy of end-stage patients
IndiTreat® Pancreatic Cancer Test
A method of determining which drugs offer the most suitable therapies for different patients with pancreatic cancer. Multi-center clinical validation trials are ongoing. This test is used before:
- Postoperative adjuvant therapy
- Neoadjuvant therapy if a pancreatic biopsy is feasible
- 1st and 2nd line palliative therapy
Contact us
Please contact 2cureX for more information
Email: info@2cureX.com
Phone: +45 22115399
Web: www.IndiTreat.com